Over the past two decades, competition in the pharmaceutical industry has been characterized by three factors: 1. Competitive advantage driven by blockbuster drugs 2. Vertical integration from discovery through sales 3. Peripheral role as suppliers in the health care system In this environment, suc
Applied genomics: integration of the technology within pharmaceutical research and development
โ Scribed by Mark Cockett; Nicholas Dracopoli; Elliott Sigal
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 154 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0958-1669
No coin nor oath required. For personal study only.
โฆ Synopsis
Multiple novel technologies have recently been developed to improve the analysis of genetic sequences, to rapidly assess RNA or protein levels in relevant tissues, and to validate function of potential new drug targets. The challenge facing pharmaceutical research is one of effective integration of these new technologies in ways that can maximally affect the discovery and development pipeline. Although database mining and transcriptional profiling clearly have increased the number of putative targets, the current focus is to assign function to new gene targets in a high-throughput manner. This requires a restructuring of the classical linear progression from gene identification, functional elucidation, target validation and screen development. New approaches are called for that can make this process non-linear and high-throughput.
๐ SIMILAR VOLUMES
Technology development at the interface of proteome research and genomics: Mapping nonpolymorphic proteins on the physical map of mouse chromosomes Data obtained from protein spots by peptide mass fingerprinting are used to identify the corresponding genes in sequence databases. The relevant cDNAs a